PubMed Health⌕ Search

PubMed · 12436838

General-purpose infusion pumps.

Abstract

General-purpose infusion pumps deliver liquid medications and other solutions to patients through intravenous (i.v.) or epidural routes at specified flows. They are most often used when greater accuracy or higher flows are needed than can be provided by manually adjusted gravity systems. In this Evaluation (which updates our February 1997 and April-May 1998 studies), we present our findings for four newly evaluated pumps from three suppliers: the Abbott Plum A+, the Alaris Medley Medication Safety System (MSS), and the Baxter Colleague CX and 3 CX. We also summarize our findings and update our ratings for 22 additional models. As our findings show, the factors that distinguish one pump from another are not performance issues, but rather patient safety considerations. Most of the currently available pumps perform reliably and accurately when properly used. However, not all models offer the same level of protection against pump programming errors and other events that can lead to i.v. medication errors. The pumps that we now recommend for consideration all incorporate a new type of safety feature that warns users when a programmed dose falls outside pre-defined "safe" limits. We call this feature a dose error reduction system. In addition, the recommended models all offer set-based free-flow protection that cannot be defeated. Pumps that lack one or both of these features are now rated either Not Recommended or Unacceptable.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

2002. General-purpose infusion pumps.. https://pubmed.ncbi.nlm.nih.gov/12436838/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Cost of cancer care: issues and implications.

Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general (and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.

Biomedical Technology↗